Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 13/2016

01-12-2016 | Original Article

Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach

Authors: Ulf Lützen, Maaz Zuhayra, Marlies Marx, Yi Zhao, Christian Colberg, Stephanie Knüpfer, René Baumann, Katharina Charlotte Kähler, Klaus-Peter Jünemann, Carsten Maik Naumann

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 13/2016

Login to get access

Abstract

Purpose

The international guidelines recommend sentinel lymph node biopsy (SLNB) for lymph node staging in penile cancer with non-palpable inguinal lymph nodes (LN) but it is not recommended with palpable inguinal LN. The aim of this study was to evaluate the reliability and morbidity of SLNB in combination with an ultrasound-guided resection of suspect inguinal LNs as a new multimodal, minimally invasive staging approach in these patients.

Methods

We performed SLNB in 26 penile cancer patients with 42 palpable inguinal LNs. Prior to the combined staging procedures the patients underwent an ultrasound examination of the groins as well as planar lymphatic drainage scintigraphy and SPECT/CT scans. During the surgical procedure, the radioactive-labelled sentinel lymph nodes and, in addition, sonographically suspect LNs, were resected under ultrasound guidance. Follow-up screening was done by ultrasound examination of the groins according to the guidelines of the European Association of Urology.

Results

Nineteen groins of 42 preoperatively palpable inguinal findings were histologically tumor-positive. SLNB alone showed lymphogenic metastases in 14 groins. Sonography revealed five further metastatic groins, which would not have been detected during SLNB due to a tumor-related blockage of lymphatic drainage or a so-called re-routing of the tracer. During follow-up, none of the 28 groins with tumor-negative LN status showed any LN recurrence in this combined investigation technique. The median follow-up period was 46 (24 to 92) months. Morbidity of this procedure was low at 4.76 % in relation to the number of groins resp. 7.69 % in relation to the number of patients.

Conclusions

The results show that this combined procedure is a reliable multimodal diagnostic approach for treatment of penile cancer patients with palpable inguinal LNs. It is associated with low morbidity rates. SLNB alone would lead to a significantly higher false-negative rate in these patients. The encouraging results of this work can extend the range of indications for nuclear medicine in the form of SLNB using radioactive tracers in this patient group.
Literature
1.
McDougal WS, Kirchner FK, Edwards RH, Killion LT. Treatment of carcinoma of the penis: the case for primary lymphadenectomy. J Urol. 1986;136:38–41.PubMed
2.
Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MPW, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol. 2005;173:816–9.CrossRefPubMed
3.
Hakenberg OW, Compérat EM, Minhas S, Necchi A, Protzel C, Watkin N, et al. EAU guidelines on penile cancer: 2014 update. Eur Urol. 2015;67:142–50.CrossRefPubMed
4.
Vogt H, Schmidt M, Bares R, Brenner W, Grünwald F, Kopp J, et al. Procedure guideline for sentinel lymph node diagnosis. Nukl Nucl Med. 2010;49:167–72. quiz N19.CrossRef
5.
Poppel HV, Watkin NA, Osanto S, Moonen L, Horwich A, Kataja V. Penile cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi115–24.PubMed
6.
Ornellas AA, Seixas AL, Marota A, Wisnescky A, Campos F, de Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994;151:1244–9.PubMed
7.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. part 1: diagnosis of lymph node metastasis. BJU Int. 2001;88:467–72.CrossRefPubMed
8.
Kroon BK, Horenblas S, Estourgie SH, Lont AP, Valdés Olmos RA, Nieweg OE. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J Urol. 2004;171:2191–4.CrossRefPubMed
9.
Leijte JAP, van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, Horenblas S. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med Off Publ Soc Nucl Med. 2009;50:364–7.
10.
Bevan-Thomas R, Slaton JW, Pettaway CA. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol. 2002;167:1638–42.CrossRefPubMed
11.
Stuiver MM, Djajadiningrat RS, Graafland NM, Vincent AD, Lucas C, Horenblas S. Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis. Eur Urol. 2013;64:486–92.CrossRefPubMed
12.
Gopman JM, Djajadiningrat RS, Baumgarten AS, Espiritu PN, Horenblas S, Zhu Y, et al. Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int. 2015;116:196–201.CrossRefPubMed
13.
Leijte JAP, Hughes B, Graafland NM, Kroon BK, Olmos RAV, Nieweg OE, et al. Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:3325–9.CrossRef
14.
Fuchs J, Hamann MF, Schulenburg F, Knüpfer S, Osmonov D, Lützen U, et al. [Sentinel lymph node biopsy for penile carcinoma : assessment of reliability]. Urol Ausg A. 2013;52:1447–50.CrossRef
15.
Saiag P, Bernard M, Beauchet A, Bafounta M-L, Bourgault-Villada I, Chagnon S. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol. 2005;141:183–9.CrossRefPubMed
16.
Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahl T. European Association of Urology. EAU Guidelines on Penile Cancer. Eur Urol. 2004;46:1–8.CrossRefPubMed
17.
Naumann CM, Alkatout I, Hamann MF, Al-Najar A, Hegele A, Korda JB, et al. Interobserver variation in grading and staging of squamous cell carcinoma of the penis in relation to the clinical outcome. BJU Int. 2009;103:1660–5.CrossRefPubMed
18.
Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, et al. Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders’ grading of penile squamous cell carcinomas. Urol Int. 2013;90:207–13.CrossRefPubMed
19.
Mueller-Lisse UG, Scher B, Scherr MK, Seitz M. Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy. Curr Opin Urol. 2008;18:105–10.CrossRefPubMed
20.
Hughes B, Leijte J, Shabbir M, Watkin N, Horenblas S. Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer. World J Urol. 2009;27:197–203.CrossRefPubMed
21.
Kochhar R, Taylor B, Sangar V. Imaging in primary penile cancer: current status and future directions. Eur Radiol. 2010;20:36–47.CrossRefPubMed
22.
Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H. Management of the lymph nodes in penile cancer. Urology. 2010;76:S43–57.CrossRefPubMed
23.
Hungerhuber E, Schlenker B, Frimberger D, Linke R, Karl A, Stief CG, et al. Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes. World J Urol. 2006;24:319–24.CrossRefPubMed
24.
Heyns CF, Theron PD. Evaluation of dynamic sentinel lymph node biopsy in patients with squamous cell carcinoma of the penis and palpable inguinal nodes. BJU Int. 2008;102:305–9.CrossRefPubMed
25.
Krishna RP, Sistla SC, Smile R, Krishnan R. Sonography: an underutilized diagnostic tool in the assessment of metastatic groin nodes. J Clin Ultrasound JCU. 2008;36:212–7.CrossRefPubMed
26.
Lam W, Kaul A, Ayres B, Corbishley C, Perry M, Sharma D, et al. The role of ultrasound in the detection of inguinal nodal metastasis in patients with primary squamous cell carcinoma of the penis: a prospective cohort analysis of 726 inguinal basins assessed in a single institution. Eur Urol Suppl. 2014;13:e56.CrossRef
27.
Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, et al. EAU penile cancer guidelines 2009. Eur Urol. 2010;57:1002–12.CrossRefPubMed
28.
Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 2005;95:517–21.CrossRefPubMed
29.
Saisorn I, Lawrentschuk N, Leewansangtong S, Bolton DM. Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int. 2006;97:1225–8.CrossRefPubMed
30.
Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med Off Publ Soc Nucl Med. 2003;44:1413–20.
31.
Schillaci O, Danieli R, Manni C, Simonetti G. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun. 2004;25:705–10.CrossRefPubMed
32.
Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol. 2005;33:78–82.PubMed
33.
van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, Rutgers EJT, Kroon BBR, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med Off Publ Soc Nucl Med. 2007;48:1756–60.
34.
von Forstner C. Der Einsatz von SPECT/CT bei der Wächterlymphknotendiagnostik. Nukl. 2011;34:59–65.
35.
Vidal-Sicart S, Brouwer OR, Mathéron HM, Bing Tan I, Valdés-Olmos RA. Sentinel node identification with a portable gamma camera in a case without visualization on conventional lymphoscintigraphy and SPECT/CT. Rev Esp Med Nucl E Imagen Mol. 2013;32:203–4.
36.
Jeschke S, Beri A, Grüll M, Ziegerhofer J, Prammer P, Leeb K, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol. 2008;53:126–32.CrossRefPubMed
37.
Mára M, Fanta M, Sláma J, Zikán M, Kubínová K, Kužel D, et al. [Laparoscopic lymph-node dissection in gynecological surgery]. Ceská Gynekol. Ceská Lékarská Spolecnost J Ev Purkyne. 2012;77:320–6.
38.
Warncke SH, Mattei A, Fuechsel FG, Z’Brun S, Krause T, Studer UE. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol. 2007;52:126–32.CrossRefPubMed
39.
Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. Semin Nucl Med. 2007;37:29–33.CrossRefPubMed
40.
Kobayashi K, Ramirez PT, Kim EE, Levenback CF, Rohren EM, Frumovitz M, et al. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med. 2009;34:859–61.CrossRefPubMed
41.
Khafif A, Schneebaum S, Fliss DM, Lerman H, Metser U, Ben-Yosef R, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck. 2006;28:874–9.CrossRefPubMed
42.
Uren RF. SPECT/CT Lymphoscintigraphy to locate the sentinel lymph node in patients with melanoma. Ann Surg Oncol. 2009;16:1459–60.CrossRefPubMed
43.
Kraft O, Havel M. Detection of sentinel lymph nodes by SPECT/CT and planar scintigraphy: the influence of age, gender and BMI. J Biomed Graph Comput. 2012;2:p11.
44.
Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging. 2006;33:329–37.CrossRefPubMed
45.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, et al. SPECT/CT. J Nucl Med Off Publ Soc Nucl Med. 2008;49:1305–19.
46.
Kraft O. Sentinel lymph node identification in breast cancer - comparison of planar Scintigraphy and SPECT/CT. Open Nucl Med J. 2012;4:5–13.CrossRef
47.
48.
Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O’Byrne MM, Port JD, et al. Incidental findings in imaging research: evaluating incidence, benefit, and burden. Arch Intern Med. 2010;170:1525–32.CrossRefPubMedPubMedCentral
Metadata
Title
Value and efficiency of sentinel lymph node diagnostics in patients with penile carcinoma with palpable inguinal lymph nodes as a new multimodal, minimally invasive approach
Authors
Ulf Lützen
Maaz Zuhayra
Marlies Marx
Yi Zhao
Christian Colberg
Stephanie Knüpfer
René Baumann
Katharina Charlotte Kähler
Klaus-Peter Jünemann
Carsten Maik Naumann
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 13/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3482-6

Other articles of this Issue 13/2016

European Journal of Nuclear Medicine and Molecular Imaging 13/2016 Go to the issue

Editorial

Standardization of administered activities in paediatric nuclear medicine: the EANM perspective

Review Article

SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease

Letter to the Editor

The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios

Editorial Commentary

Crossing technological frontiers in radioguided intervention

Original Article

Fusion of freehand SPECT and ultrasound: First experience in preoperative localization of sentinel lymph nodes

Original Article

18F-FDG PET/CT heterogeneity quantification through textural features in the era of harmonisation programs: a focus on lung cancer